Previous 10 | Next 10 |
Dr. Reddy's Laboratories (RDY) and Shenzhen Pregene Biopharma announce an agreement whereby Dr Reddy's will acquire an exclusive license in India for PRG1801, Pregene's single domain antibody-based anti-BCMA chimeric antigen receptor T (CAR-T) cell therapy injection.Dr. Reddy's acquires the e...
Dr. Reddy’s Laboratories (RDY) announces the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of Merck's INVANZ (ertapenem for injection) for injection, 1 g/vial. The INVANZ brand and generic market had U.S. sales of ~$205M for twelve months ended M...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version...
Dr. Reddy's Laboratories ([[RDY]] +0.3%) has entered into a licensing agreement with Eli Lilly ([[LLY]] -0.0%) to manufacture the rheumatoid arthritis drug Baricitinib in India for the treatment of COVID-19, PTI news agency reports.The royalty-free, non-exclusive voluntary licensing agreement...
Dr. Reddy's Laboratories (NYSE: RDY) may be one of the best medical stocks you haven't heard of. The pharmaceutical company concentrates on generic and biosimilar medicines for cardiovascular disease, pain management, oncology, gastrointestinal ailments, dermatology, anti-infection ...
Bargain stocks are extremely difficult to come by these days. Investors have already scooped up many of these stocks during the S&P 500 's monstrous 45% gain over the past 12 months. Luckily, there are still opportunities available in the form of American Depositor...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Albendazole Tablets, USP, a therapeutic equivalent generic version of Albenz...
Dr. Reddy’s Laboratories (RDY) has received the permission from the Drug Controller General of India ((DCGI)) to import the Sputnik vaccine into India for restricted use in emergency situations. In September 2020, Dr. Reddy’s had partnered with the Russian Direct Investment...
In a very surprising statement, Gao Fu (the head of the Chinese Center for Disease Control and Prevention) said at a conference in Chengdu over the weekend that the protection figures of the Chinese vaccines are "not high". The “Sputnik-V” vaccine from the Gamaleya Insti...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) today announced that it has received the permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations as per t...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...